US 9682097
Oligonucleotide analogues targeting human LMNA
granted A61KA61K31/713A61K47/6455
Quick answer
US patent 9682097 (Oligonucleotide analogues targeting human LMNA) held by Sarepta Therapeutics, Inc. expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 49
- CPC classes
- A61K, A61K31/713, A61K47/6455, A61P, A61P43/00